NPC at AMCP 2023 Annual Meeting

Join NPC at AMCP 2023 and hear Dr. John M. O'Brien's panel remarks during the pre-conference session AMCP Talks, on March 21. 

Join NPC in San Antonio, TX at AMCP 2023 and hear Dr. John M. O'Brien's panel remarks during "AMCP Talks"

Pre-conference Session | Tuesday, March 21 | 4:00 PM – 5:30 PM CT

AMCP Talks: Incorporating Value Framework Assessments in Coverage and Reimbursement Decisions

Session Description

Value frameworks and assessments are increasingly used as a resource for evaluating the value of pharmaceuticals and other health technologies in coverage and negotiation processes. These frameworks are designed to help health care decision-makers determine the comparative effectiveness and value of a medication or intervention. These frameworks continue to evolve and are designed for different decision-making applications and target audiences.

According to a recent survey of payers, the most important factors when selecting a framework to inform decision-making are the metrics and outcomes, comparative clinical effectiveness information, methodologic rigor, and transparency. Although payers agree on these important factors, their decision-making processes and incorporation of value assessment information in these decisions can differ vastly. This session aims to explore:
• payer decision-making processes and structures,
• current sources and use of value assessments in these decisions,
• future value assessment information needs, and
• the potential impact of the Inflation Reduction Act.

Hear from various payer perspectives, real-world strategies for incorporating and assessing value in their coverage and reimbursement decision-making.

Learning Objectives::

At the completion of this activity, participants should be able to:

  1. Explain how value framework assessments are utilized in managed care practice.
  2. Describe at least two strategies payers use to incorporate value frameworks into decision-making.
  3. Identify opportunities for bolstering the relevance and usefulness of value framework assessments for payer decision-making.


  • Pat Gleason, PharmD, Assistant Vice President, Prime Therapeutics
  • Jessica Hatton, PharmD, BCACP, Associate Vice President, Pharmacy CareSource
  • John M. O'Brien, PharmD, MPH, President & CEO, National Pharmaceutical Council
  • Brenden O'Hara, RPh, BCACP, Team Leader, Provider Engagement Pharmacy Initiatives, Blue Cross NC


  • Kimberly Westrich, MA, Director, Value & Access Strategy, Xcenda/AmerisourceBergen

NPC is also excited to sponsor the AMCP Chapter Leadership Academy Breakfast

Thursday, March 23 | 8:00 AM - 9:00 AM CT 

(This is a closed AMCP invitation-only session)

Session Description: 

The AMCP Chapter Leadership Academy (CLA) is held in conjunction with AMCP's Annual Meeting each year. The CLA brings together officers and advisors from each of the AMCP Student Chapters to equip them with tools and best practices to improve their chapter's experiences. The CLA also features a keynote address and networking opportunities with other chapter leaders.

NPC President and CEO Dr. John M. O'Brien will provide remarks at the close of the breakfast before the Academy kicks off.